News

Our Healthcare News

Laboratoires Majorelle appoints Alexandre de Germay as Chief Executive Officer

PARIS, France—Laboratoires Majorelle, a fast-growing French specialty pharma company focused on prescription and OTC products in women’s health and urology, today announces the appointment of…  

Oct 20 2021

EW Healthcare Partners Announces the Promotion of Senior Executives

NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the promotion of…  

Oct 04 2021

EW Healthcare Partners Announces the Acquisition of a Majority Stake in Laboratoires Majorelle

London, UNITED KINGDOM—EW Healthcare Partners (“EW”) has acquired a majority stake in Laboratoires Majorelle (“Majorelle”) from its Founders to support its growth and European expansion…  

Apr 30 2021

Bioventus Acquires Bioness, Inc.

DURHAM, North Carolina –– Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc. (“Bioness”),…  

Mar 30 2021

Charles River Laboratories Completes the Acquisition of Cognate BioServices

WILMINGTON, Mass.—(BUSINESS WIRE)—Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Cognate BioServices, Inc. for approximately…  

Mar 29 2021

Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development

– Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector –

– Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO…  

Feb 17 2021

Bioventus Announces Pricing of Initial Public Offering

DURHAM, North Carolina(GLOBE NEWSWIRE)—Bioventus Inc. (“Bioventus” or the “Company”) today announced the pricing of its initial public offering of 8,000,000 shares of Class A common…  

Feb 10 2021

EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of EYP-1901 for the Treatment of Wet AMD

WATERTOWN, Massachusetts (GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with…  

Jan 28 2021

Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio

BOSTON, Massachusetts—PRNewswire—Haemonetics Corporation (NYSE: HAE) (“Haemonetics”), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that…  

Jan 20 2021



View Legacy Fund news >